Double-Expressor Lymphoma
Conditions
Interventions
Observation group:None
Sponsors
Chongqing University Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age range: 18 - 80 years old, gender not restricted; 2. Confirmed double-expression lymphoma: having overexpression of both c-Myc and Bcl-2 proteins, while fluorescence in situ hybridization analysis did not show gene rearrangement in diffuse large B-cell lymphoma; 3. Complete medical history including 18F-FDG PET/CT, clinical and pathological data.
Exclusion criteria
Exclusion criteria: 1. Presence of two or more concurrent malignant tumors; 2. Incomplete medical history data; 3. The investigator considers that the subject may not be able to complete the study or comply with the study requirements (due to administrative or other reasons).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PET/CT related parameters (SUVmax, SUVpeak, Dmaxbulk, Dmaxpatient, BVG, etc.; measurement of Euclidean distance, Manhattan distance, Chebyshev distance);Clinical indicators ( IPI score, LDH level, age, Ann Arbor stage, treatment plan, etc.);Pathological features (c-Myc, Bcl-2, Ki-67, CD5, TP53, etc.); | — |
Countries
China
Contacts
Public ContactXiaoliang Chen
Chongqing University Cancer Hospital
Outcome results
None listed